v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash Flows from Operating Activities:    
Net income $ 156,984 $ 90,609
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 142,765 137,185
Amortization of debt related items 7,015 1,721
Gain from sale or disposition of assets (3,840) (8,739)
Asset impairment loss 2,067 0
Deferred income tax expense (benefit) 2,453 (3,815)
Equity in (earnings) loss of joint ventures (1,737) 26,629
Distributions of equity in earnings of joint ventures 5,879 5,787
Changes in current assets and current liabilities (Note 11) 1,080 116,838
Other, net 2,529 12,325
Net cash provided by operating activities 315,195 378,540
Cash Flows from Investing Activities:    
Capital expenditures (229,548) (260,701)
Change in accounts payable related to capital expenditures 10,910 (2,879)
Proceeds from sale or disposition of assets 25,975 116,467
Increase in note receivable from related party (13,328) (50,761)
Other, net (853) 156
Net cash used in investing activities (206,844) (197,718)
Cash Flows from Financing Activities:    
Proceeds from long-term debt borrowings 537,436 1,299,220
Proceeds from note offering, net of issuance costs 0 687,151
Proceeds from short-term debt borrowings 205,200 0
Long-term debt repayments (451,269) (1,897,182)
Short-term debt repayments (183,800) 0
Distributions to unitholders and general partner (294,153) (294,153)
Payments for termination of interest rate swaps 0 (33,697)
Other, net 2,540 3,168
Net cash used in financing activities (184,046) (235,493)
Effect of foreign exchange rate changes on cash 638 (4,412)
Net decrease in cash and cash equivalents (75,057) (59,083)
Cash and cash equivalents as of the beginning of the period 100,743 83,602
Cash and cash equivalents as of the end of the period $ 25,686 $ 24,519